Here’s the FDA’s Final Guidance on Cannabis and Clinical Research 

The FDA’s long-awaited guidance for non-medical products containing CBD, which are already widely available despite being unregulated, is still in the works.

United States

U.S. Sentencing Commission Proposes New Approach to Cannabis Offenses

Should federal courts consider cannabis possession when calculating someone’s criminal history? This and other questions are up for debate.


Exclusive: Cannabis Wire Goes One-on-One with FDA’s Leading Advisor on Cannabis

Norm Birenbaum, the FDA’s senior public health advisor on cannabis, spoke with Cannabis Wire about his new role and his priorities for 2023.